Skip to main content

Table 3 Relative risk for adverse pregnancy outcomes in RA and SLE

From: Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus

 

RA*

SLE

Hypertension/preelampsia

Possibly

20 %

Preterm delivery including PPROM

Odds ratio 1.5 compared to controls

40 %

C-section rate

Increased

Increased

SGA

Yes

Yes

Fetal/neonatal death

No

17 %

Anti-Ro/SSA, Anti-La/ SSB positive patients

  

 Neonatal lupus

14–20 %

14–20 %

 CCHB

2 %, recurrence rate 17 %

2 %, recurrence rate 17 %

  1. *RA patients are less commonly positive for anti-Ro/SS-A and anti-La/SS-B antibodies than are patients with SLE, but when antibody-positive these patients are subject to the same risk for neonatal lupus in their offspring